Underutilization of AUD medications is attributed to multiple factors, including few Food and Drug Administration (FDA)approved therapies, limited awareness of these medications, and barriers related to stigma, wrote a team of investigators led by Christian Hendershot, Ph.D., director of clinical research at University of Southern Californias Institute for Addiction Science and associate professor at Bowles Center for Alcohol Studies
Retatrutide is still investigational, has not been approved by regulators and cannot legally be prescribed or supplied as a weight loss treatment
However, it is noteworthy that within the organic acidemia cohort, five patients had biochemical evidence of attenuated microbial carnitine-TMAO conversion, e.g., low-to-normal plasma TMAO levels
Weight Management : Semaglutide is also used to help with weight loss
As we talked briefly about above, liraglutide is a GLP-1 medication